Your browser doesn't support javascript.
loading
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Wang, Justin Z; Patil, Vikas; Liu, Jeff; Dogan, Helin; Tabatabai, Ghazaleh; Yefet, Leeor S; Behling, Felix; Hoffman, Elgin; Bunda, Severa; Yakubov, Rebecca; Kaloti, Ramneet; Brandner, Sebastian; Gao, Andrew; Cohen-Gadol, Aaron; Barnholtz-Sloan, Jill; Skardelly, Marco; Tatagiba, Marcos; Raleigh, David R; Sahm, Felix; Boutros, Paul C; Aldape, Kenneth; Nassiri, Farshad; Zadeh, Gelareh.
Afiliación
  • Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Patil V; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Liu J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Dogan H; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Tabatabai G; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Yefet LS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Behling F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Hoffman E; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Bunda S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Yakubov R; Department of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany.
  • Kaloti R; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.
  • Brandner S; Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, Germany.
  • Gao A; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Cohen-Gadol A; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Barnholtz-Sloan J; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Skardelly M; Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, Germany.
  • Tatagiba M; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Raleigh DR; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Sahm F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Boutros PC; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Aldape K; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Nassiri F; Division of Neuropathology, UCL Queen Square Institute of Neurology, London, UK.
  • Zadeh G; Division of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada.
Acta Neuropathol ; 146(1): 171-172, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37171636
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Acta Neuropathol Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Acta Neuropathol Año: 2023 Tipo del documento: Article País de afiliación: Canadá